The sociology of cognitive enhancement: Medicalisation and beyond
The sociology of cognitive enhancement: Medicalisation and beyond
复制标题
DOI：
10.5172/hesr.2011.20.4.381
复制
发表时间：
2011-12-01
影响因子：
3.6
通讯作者：
Williams, Simon
中科院分区：
文献类型：
--
作者：
Coveney, Catherine;Gabe, Jonathan;Williams, Simon
迄今为止，健康和医学社会学仅以有限的方式参与了关于认知增强药物以及它们如何影响或改变我们生活方式的辩论。在这篇综述中，我们探讨了这些药物的发展，现在和未来的影响，特别是随着时间的推移，不断变化的驱动程序和动态的医疗或生物医学。虽然这两个概念揭示了这些发展的重要意义，但药物化提供了一个更精确的社会学参考范围，我们建议跟踪和跟踪这些趋势，随着时间的推移，认知增强药物。最后，本文提出了一些进一步的建议，在这一领域的研究议程，利用位于科学技术研究（STS）和健康和生物医学社会学之间的联系的概念。
To date, sociology of health and medicine has engaged in only a limited way in debates about cognitive enhancement drugs and how they might affect or change the way we live our lives. In this review we explore the implications of the development of such drugs, both now and in the future, with particular reference to the changing drivers and dynamics of medicalisation or biomedicalisation over time. Whilst both concepts shed important light on these developments, pharmaceuticalisation provides a more precise sociological term of reference we suggest for tracing and tracking these trends in cognitive enhancing drugs over time. The paper ends with some further suggestions for a research agenda in this domain, drawing on concepts located at the nexus between science and technology studies (STS) and the sociology of health and biomedicine.